Global Fatigue Pipeline Review 2016: Focus on 5 Companies & 6 Drug Profiles - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Fatigue - Pipeline Review, H2 2016" report to their offering.

Fatigue Fatigue also referred to as tiredness, exhaustion, lethargy, listlessness, and describes a physical and/or mental state of being tired and weak. Signs and symptoms include aching or sore muscles, painful lymph nodes, chronic (long-term) tiredness, dizziness, headache, irritability and loss of appetite.

Fatigue pipeline therapeutics constitutes close to 6 molecules. which approximately 6 molecules are developed by Companies. The molecules developed by Companies in Pre-Registration, Phase II, IND/CTA Filed and Preclinical stages are 1, 3, 1 and 1 respectively.

Fatigue - Pipeline Review, H2 2016, outlays comprehensive information on the therapeutics under development for Fatigue, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews of key players involved in therapeutic development for Fatigue and features dormant and discontinued projects.

Key Topics Covered:

  1. Introduction
  2. Fatigue Overview
  3. Therapeutics Development
  4. Pipeline Products for Fatigue - Overview
  5. Pipeline Products for Fatigue - Comparative Analysis
  6. Fatigue - Therapeutics under Development by Companies
  7. Fatigue - Therapeutics under Investigation by Universities/Institutes
  8. Fatigue Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Fatigue - Products under Development by Companies
  13. Fatigue - Products under Investigation by Universities/Institutes
  14. Fatigue - Companies Involved in Therapeutics Development
  • BioLite, Inc.
  • Biovista Inc.
  • Grifols, S.A.
  • Hemispherx Biopharma, Inc.
  • MultiCell Technologies, Inc.

For more information about this report visit http://www.researchandmarkets.com/research/7xdm4q/fatigue

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Central Nervous System Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Central Nervous System Drugs